Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease [Phase 2]

View source ↗

Summary

An early-phase (Phase 2) study is evaluating the efficacy and safety of TTYP01 tablets in individuals with early symptomatic Alzheimer's disease and is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• TTYP01 Tablets

Snippet

Sponsor: Shanghai Auzone Biological Technology Co., Ltd. | Conditions: AD, Early Alzheimer's Disease | Phase 2 | Status: RECRUITING